Advanced Center for Human Genetics, Sher-I-Kashmir Institute of Medical Sciences (SKIMS), Srinagar, Jammu and Kashmir, India.
School of Life and Basic Sciences, Jaipur National University, Jaipur, Rajasthan, India.
Int J Gynaecol Obstet. 2024 Sep;166(3):1285-1296. doi: 10.1002/ijgo.15496. Epub 2024 Mar 25.
Studies have investigated miR-125a for its predictable role in recurrent pregnancy loss (RPL) cases to regulate many biological events required for the maintenance of pregnancy by regulating its confirmed target genes LIFR, ERBB2 and STAT3.
The present study included 40 cases of women with at least two RPLs in ≤20 weeks of gestation against 40 healthy multiparous women without a previous history of abortion. Expression analysis of ERBB2, LIFR, STAT3 and miR-125a was conducted by quantitative real-time PCR (qPCR).
The expression of miR-125a was significantly lower in the plasma of RPL cases (P = 0.0001) and showed a significantly increased mean expression level in product of conception (2.56-fold, P < 0.0001). Among the target gene of miR-125a, ERBB2 and STAT3 gene expression level was significantly increased (2.58-fold, P = 0.04; 1.87-fold, P = 0.025), respectively in RPL cases while the LIFR gene revealed comparable expression (P = 0.64). Furthermore, expression analysis of ERBB2 gene with respect to its regulatory miR-125a cases depicted a significant association (P = 0.0005). Kaplan-Meier survival analysis revealed cases with low miR-125a expression had significantly shorter time to miscarriages, (log-rank P = 0.02). Also, decreased expression of miR-125a significantly conferred >2-fold increased risk for RPL (HR = 2.34: P < 0.05).
The overall conclusion of the study was that altered miR-125a expression may cause deregulation in target genes LIFR, ERBB2 and STAT3 resulting in adverse consequence in the outcome of pregnancy.
已有研究表明 miR-125a 在复发性流产(RPL)病例中具有可预测作用,通过调节其明确的靶基因 LIFR、ERBB2 和 STAT3,调控维持妊娠所需的许多生物学事件。
本研究纳入了 40 例妊娠 20 周内至少发生 2 次 RPL 的女性病例,以及 40 例无既往流产史的健康多产妇作为对照。采用实时荧光定量 PCR(qPCR)检测 ERBB2、LIFR、STAT3 和 miR-125a 的表达。
RPL 病例血浆中 miR-125a 的表达明显降低(P=0.0001),并在妊娠产物中表现出明显升高的平均表达水平(2.56 倍,P<0.0001)。miR-125a 的靶基因中,ERBB2 和 STAT3 基因的表达水平分别显著升高(2.58 倍,P=0.04;1.87 倍,P=0.025),而 LIFR 基因的表达则无显著差异(P=0.64)。此外,miR-125a 病例的 ERBB2 基因表达分析表明两者存在显著相关性(P=0.0005)。Kaplan-Meier 生存分析显示,miR-125a 低表达的病例发生流产的时间明显缩短(log-rank P=0.02)。此外,miR-125a 表达降低显著使 RPL 的风险增加了 2 倍以上(HR=2.34:P<0.05)。
本研究的总体结论是,miR-125a 表达的改变可能导致靶基因 LIFR、ERBB2 和 STAT3 的失调,从而对妊娠结局产生不良影响。